Simon Thomas
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Martin Pulé (14 shared papers)Brian Philip (5 shared papers)Karin C. M. Straathof (2 shared papers)Evangelia Kokalaki (6 shared papers)Barry R Flutter (1 shared paper)Ronjon K. Chakraverty (3 shared papers)Karl S. Peggs (3 shared papers)Teresa Marafioti (1 shared paper)
- Journals
- Blood (6 papers)Nature Medicine (2 papers)ACS Chemical Biology (1 paper)BioTechniques (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Simon Thomas
23 papers receiving 1.2k citations
Simon Thomas's Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 955
- Immunology 287
- Genetics 286
- Biomedical Engineering 326
- Hematology 75
Countries citing papers authored by Simon Thomas
This map shows the geographic impact of Simon Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Thomas more than expected).
Fields of papers citing papers by Simon Thomas
This network shows the impact of papers produced by Simon Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Thomas. The network helps show where Simon Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 346 | |
| 2 | CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial Hit paper breakdown → | 2021 | 224 |
| 3 | 2020 | 161 | |
| 4 | 2017 | 148 | |
| 5 | 2018 | 76 | |
| 6 | 2018 | 59 | |
| 7 | 2016 | 54 | |
| 8 | 2023 | 30 | |
| 9 | 2021 | 22 | |
| 10 | 2024 | 19 | |
| 11 | 2015 | 17 | |
| 12 | 2024 | 15 | |
| 13 | 2023 | 9 | |
| 14 | 2014 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2024 | 6 | |
| 17 | 2017 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2014 | 4 | |
| 20 | 2022 | 4 |
About Simon Thomas
Simon Thomas is a scholar working on Oncology, Genetics, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Nanowire Synthesis and Applications (4 papers), Advancements in Semiconductor Devices and Circuit Design (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Oncology (955 citations), Immunology (287 citations), Genetics (286 citations), Biomedical Engineering (326 citations) and Hematology (75 citations). Simon Thomas has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Martin Pulé, Brian Philip, Karin C. M. Straathof, Evangelia Kokalaki, Barry R Flutter, Ronjon K. Chakraverty, Karl S. Peggs, Teresa Marafioti, David C. Linch and Virna Marin. Their work appears in journals such as Blood, Nature Medicine, ACS Chemical Biology, BioTechniques and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.